• NO METAL IMPLANT
  • COMPLETE SEALING
  • SIMPLIFYING PROCEDURE

THE NEED

Each year, 33 million people worldwide suffer a stroke, 20% of which are caused by Non Valvular Atrial Fibrillation (NVAF), a life-threatening heart rhythm disease. In AF, blood clots are formed in the LAA, a small sac in the wall of the left atrium of the heart. 90% of strokes in NVAF patients are caused by migration of these clots to the brain.

Due to the LAA’s complex structure, it is difficult to close it completely by the current marketed devices and blood clots can still leak to the brain. Another risk of these devices is the potential formation of device-related thromboembolism because of foreign material implants that are left in the heart. The implantation procedure is complicated.

OUR SOLUTION

Next Generation Left Atrial Appendage Elimination System

THE APPLIGATOR TM

CT SCAN 3 DAYS POST IN-VIVO CHRONIC PROCEDURE

INVAGINATED SEALED LAA

CT SCAN 146 DAYS POST IN-VIVO CHRONIC PROCEDURE

95% VOLUME DECREASE

The Append Medical procedure is designed to:

Leave no metal implant
in the heart

Acheive complete sealing
of the LAA opening

Simplify the procedure

APPEND MEDICAL TEAM

Zachi Berger, Phd MBA

CEO & Founder

Shay Raviv, BSc MBA

R&D Manager

Liz Zinger, MSc

VP RA/QA

Gal Yamin, BSc

Team Leader, Mechanical Engineer

Yosi Zuaretz, BSc

Mechanical Engineer

SCIENTIFIC ADVISORY BOARD

Prof. Leonid Sternik, MD

Inventor & Advisor

Prof. Horst Sievert, MD

Chairman of the SAB

Prof. Amir Halkin, MD

Medical Advisor